Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line

Gen Pharmacol. 1996 Oct;27(7):1141-3. doi: 10.1016/0306-3623(95)02150-7.

Abstract

1. A human neuroblastoma cell line, SH-SY5Y, was used to determine the effects of delta-9-tetrahydrocannabinol (THC) on microtubule-associated tau protein. 2. After 48-hr treatment, THC (10(-9) M) decreased 50 kD tau protein in the cytoplasmic (supernatant) fraction, and in the membrane (pellet) fraction the drug (10(-7) M) also decreased 50 kD tau protein. 3. This reduction in tau protein was accompanied by a 27% reduction (P < 0.05) in the membrane (pellet) total protein after (10(-7) M) THC and a 28% increase (P < 0.02) in cytoplasmic (supernatant) total protein after 10(-9) M THC.

MeSH terms

  • Blotting, Western
  • Brain Neoplasms / metabolism*
  • Depression, Chemical
  • Dronabinol / pharmacology*
  • Electrophoresis, Polyacrylamide Gel
  • Hallucinogens / pharmacology*
  • Humans
  • Microtubules / metabolism
  • Neuroblastoma / metabolism*
  • Tumor Cells, Cultured
  • tau Proteins / biosynthesis*

Substances

  • Hallucinogens
  • tau Proteins
  • Dronabinol